0001209191-24-000973.txt : 20240105
0001209191-24-000973.hdr.sgml : 20240105
20240105160025
ACCESSION NUMBER: 0001209191-24-000973
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240103
FILED AS OF DATE: 20240105
DATE AS OF CHANGE: 20240105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Yazji Salim
CENTRAL INDEX KEY: 0001864486
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50549
FILM NUMBER: 24516134
MAIL ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc.
CENTRAL INDEX KEY: 0001260990
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 621715807
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 230
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 434-1113
MAIL ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 230
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: GTX INC /DE/
DATE OF NAME CHANGE: 20030822
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-01-03
0
0001260990
Oncternal Therapeutics, Inc.
ONCT
0001864486
Yazji Salim
12230 EL CAMINO REAL, SUITE 230
SAN DIEGO
CA
92130
0
1
0
0
Chief Medical Officer
0
Common Stock
2024-01-03
4
F
0
19742
0.4961
D
128635
D
Shares withheld by the Issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units.
/s/Chase C. Leavitt, Attorney-in-fact
2024-01-05